Today, a Director at Onconova Therapeutics (NASDAQ: ONTX), Michael B. Hoffman, sold shares of ONTX for $44.8K.
This is Hoffman’s first Sell trade following 6 Buy transactions.
See today’s analyst top recommended stocks >>
Based on Onconova Therapeutics’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $485K and GAAP net loss of $4.48 million. In comparison, last year the company earned revenue of $324K and had a GAAP net loss of $2.58 million. Currently, Onconova Therapeutics has an average volume of 570.1K.
Michael B. Hoffman’s trades have generated a -60.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer.
